Page last updated: 2024-10-25

deferiprone and Abnormalities, Cardiovascular

deferiprone has been researched along with Abnormalities, Cardiovascular in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
" Here, we used deferiprone (DFP) as an iron chelating agent in TI patients receiving intermittent blood transfusion who are asymptomatic for cardiovascular disease in order to evaluate the effectiveness in iron overload and reduce the possibility of cardiovascular complications."9.15Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients. ( Akrawinthawong, K; Chaowalit, N; Chatuparisuth, T; Siritanaratkul, N, 2011)
" Here, we used deferiprone (DFP) as an iron chelating agent in TI patients receiving intermittent blood transfusion who are asymptomatic for cardiovascular disease in order to evaluate the effectiveness in iron overload and reduce the possibility of cardiovascular complications."5.15Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients. ( Akrawinthawong, K; Chaowalit, N; Chatuparisuth, T; Siritanaratkul, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akrawinthawong, K1
Chaowalit, N1
Chatuparisuth, T1
Siritanaratkul, N1

Trials

1 trial available for deferiprone and Abnormalities, Cardiovascular

ArticleYear
Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.
    Hematology (Amsterdam, Netherlands), 2011, Volume: 16, Issue:2

    Topics: Adolescent; Adult; beta-Thalassemia; Cardiovascular Abnormalities; Deferiprone; Echocardiography, Do

2011